North American market : Initiatives to Lessen the Demand-Supply Gap of Mo-99

Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth... Continue Reading →

North American nuclear medicine market | Professional Analysis, Opportunities, Strategies and Growth Forecast to 2024

The report "North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), Application (Oncology, Cardiology) - Forecasts to 2024", The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019,... Continue Reading →

Blog at WordPress.com.

Up ↑

Create your website at WordPress.com
Get started